Patents by Inventor Eamonn Conolly

Eamonn Conolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selection of agents modulating gastrointestinal pain
    Patent number: 11371985
    Abstract: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: June 28, 2022
    Assignee: BIOGAIA AB
    Inventors: Eamonn Conolly, Wolfgang Kunze, John Bienenstock
  • SELECTION OF AGENTS MODULATING GASTROINTESTINAL PAIN
    Publication number: 20200225214
    Abstract: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
    Type: Application
    Filed: March 30, 2020
    Publication date: July 16, 2020
    Inventors: Eamonn Conolly, Wolfgang Kunze, John Bienenstock
  • Selection of agents modulating gastrointestinal pain
    Patent number: 10656141
    Abstract: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: May 19, 2020
    Assignee: BIOGAIA AB
    Inventors: Eamonn Conolly, Wolfgang Kunze, John Bienenstock
  • Selection of Agents Modulating Gastrointestinal Pain
    Publication number: 20180259503
    Abstract: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 13, 2018
    Inventors: Eamonn Conolly, Wolfgang Kunze, John Bienenstock
  • Selection of Agents Modulating Gastrointestinal Pain
    Publication number: 20160334391
    Abstract: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
    Type: Application
    Filed: January 23, 2015
    Publication date: November 17, 2016
    Applicant: BIOGAIA AB
    Inventors: Eamonn Conolly, Wolfgang Kunze, John Bienenstock